Abstract #2072
            Multiple Sclerosis lesion fingerprint using multicontrast MRI
                      Guillaume Bonnier                     1,2                    , Alexis Roche                     1,3                    , 						David Romanasco                     4                    , Samanta Simioni                     2                    , 						Djalel-Eddine Meskaldji                     4                    , David Rotzinger                     3                    , 						Ying-Chia Lin                     5                    , Gloria Menegaz                     5                    , 						Myriam Schluep                     2                    , Renaud Du Pasquier                     2                    , 						Tilman Johannes Sumpf                     6                    , Jens Frahm                     6                    , 						Jean-Philippe Thiran                     4                    , Gunnar Krueger                     1,7                    , 						and Cristina Granziera                     1,2          
            
            1
           
           Advanced Clinical Imaging technology group, 
						Siemens-CIBM, EPFL, Lausanne, Vaud, Switzerland,
           
            2
           
           Department 
						of Clinical Neurosciences, Centre Hospitalier 
						Universitaire Vaudois and University of Lausanne, 
						Lausanne, Vaud, Switzerland,
           
            3
           
           Department 
						of Radiology, Centre Hospitalier Universitaire Vaudois 
						and University of Lausanne, Vaud, Switzerland,
           
            4
           
           STI 
						/ IEL / LTS5, EPFL, Lausanne, Vaud, Switzerland,
           
            5
           
           Dept. 
						of Computer Science, University of Verona, Itlay, Italy,
           
            6
           
           Biomedizinische 
						NMR Forschungs GmbH, Max Planck Institute for 
						Biophysical Chemistry, Gottingen, Germany, Germany,
           
            7
           
           Healthcare 
						Sector IM&WS S, Siemens Schweiz AG, Lausanne, Vaud, 
						Switzerland
          
            
          Conventional magnetic resonance imaging (MRI) measures 
						of multiple sclerosis patients provide limited 
						information about the nature and the extent of brain 
						damage and repair. We established a clinically 
						compatible protocol including quantitative MRI 
						techniques (qMRI, T1, T2, T2* relaxometry) and 
						semiquantitative Magnetisation Transfer Imaging to 
						provide a comprehensive MRI fingerprint (CMF) of lesions 
						that is more adherent to the real underlying pathology 
						and to assess the CMF contribution to clinical 
						performances in patients. Lesions characteristics, 
						revealed by combination of q/sq MRI, highly correlated 
						with patients clinical performance and more severe 
						lesions appeared to drive the clinic-radiological 
						correlations.
         
 
            
				
					How to access this content:
					For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
					After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
					After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
					Click here for more information on becoming a member.